Centre Hospitalier Universitaire de Sherbrooke
🇨🇦Canada
Testosterone Recovery After ADT Shows 46% Lower Mortality Risk in High-Risk Prostate Cancer Study
Long-term data from the phase III PCS4 trial reveals patients who recovered normal testosterone levels after androgen-deprivation therapy showed a 46% reduction in mortality risk compared to non-recoverers.
© Copyright 2025. All Rights Reserved by MedPath